Psychiatry and Neurology, Neurology · Houston, TX
NPI
1528052982
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
19255 Park Row, Ste 101
Houston, TX, 77084
Phone (281) 816-6455
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
911 services
Medicare patients, 2024
332
Average age 73
Drug cost, 2024
$719K
4,476 prescriptions
Company payments, 2025
$591
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Atta Rehman was code 99214 (office e&m - established), 399 times for 203 patients. In total Atta Rehman billed 911 services in 17 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 399 | 203 | $85.93 | $34K |
| 99223 Hospital E&M - Initial | Facility | 87 | 84 | $129.44 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 81 | 48 | $58.97 | $4,776 |
| 95886 Electrical Nerve Conductivity | Office | 54 | 54 | $69.53 | $3,754 |
| 99204 Office E&M - New | Office | 52 | 52 | $121.73 | $6,330 |
| 95911 Electrical Nerve Conductivity | Office | 44 | 44 | $156.42 | $6,883 |
| 95819 Neurologic | Office | 34 | 34 | $340.37 | $12K |
| 99215 Office E&M - Established | Office | 30 | 29 | $129.25 | $3,878 |
| 99205 Office E&M - New | Office | 29 | 29 | $164.07 | $4,758 |
| 95816 Neurologic | Office | 28 | 28 | $292.98 | $8,203 |
| 95816 Neurologic | Facility | 21 | 20 | $42.21 | $886 |
| 95819 Neurologic | Facility | 15 | 15 | $42.31 | $635 |
By year: 2022 $106K for 1,475 services; 2023 $101K for 1,067 services; 2024 $99K for 911 services.
Medicare prescription drug claims, 2024
In 2024, the drug Atta Rehman prescribed most often to Medicare patients was Memantine Hcl, with 541 prescriptions and refills. In total Atta Rehman wrote 4,476 Medicare prescriptions that cost $719K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 541 | 849 | 141 | $13K |
| Donepezil Hcl Generic | 535 | 1,007 | 151 | $3,485 |
| Gabapentin Generic | 514 | 753 | 111 | $6,222 |
| Levetiracetam Generic | 293 | 483 | 53 | $6,588 |
| Topiramate Generic | 244 | 389 | 55 | $1,153 |
| Duloxetine Hcl Generic | 215 | 321 | 53 | $4,105 |
| Pregabalin Generic | 165 | 253 | 55 | $2,145 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 126 | 198 | 30 | $1,732 |
| Nortriptyline Hcl Generic | 111 | 169 | 28 | $1,131 |
| Propranolol Hcl Generic | 93 | 168 | 27 | $1,146 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 85 | 155 | 20 | $1,615 |
| Baclofen Generic | 76 | 121 | 21 | $1,453 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 75 | 105 | 20 | $781 |
| Memantine Hcl Er Memantine Hcl | 71 | 135 | 24 | $13K |
| Tizanidine Hcl Generic | 71 | 112 | 29 | $487 |
Brand drugs: 137 claims; generic drugs: 4,326 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Atta Rehman $591 ($591 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $173.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 12 | $173 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $135 |
| SK Life Science, Inc. | 2 | $63.51 |
| Lundbeck LLC | 2 | $33.01 |
| Aucta Pharmaceuticals, Inc. | 4 | $27.66 |
| Genentech USA, Inc. ROG.SW | 1 | $24.3 |
| Chiesi USA, Inc. | 1 | $21.91 |
| EMD Serono, Inc. MRK.DE | 1 | $21.1 |
| Mallinckrodt Hospital Products Inc. | 1 | $19.55 |
| UCB, Inc. UCB.BR | 1 | $18.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.